Cost of hypertension medications: is it a barrier to hypertension control?

Abstract

Surveys conducted in the 1970s indicated that the cost of antihypertensive drugs was seldom a barrier to the control of hypertension. More recent surveys of both patients and physicians, however, have revealed that the cost of these medications is a growing problem. Physicians have more options than were available a decade ago, and many of the newer drugs are expensive. It is important that physicians consider the cost when selecting a course of treatment for their patients.